First Wave BioPharma (NASDAQ:FWBI – Get Rating) had its target price lowered by HC Wainwright from $18.00 to $14.00 in a research note released on Wednesday morning, The Fly reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for First Wave BioPharma’s Q1 2023 earnings at ($1.69) EPS, […]